Evidence map›Paper›PMID 36505495›Full record

ArticleFrontiers in immunology2022

Rap1b-loss increases neutrophil lactate dehydrogenase activity to enhance neutrophil migration and acute inflammation

Chanchal Sur Chowdhury, Elizabeth Wareham, Juying Xu, Sachin Kumar, Matthew Kofron, Sribalaji Lakshmikanthan, Magdalena Chrzanowska, Marie-Dominique Filippi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Chanchal Sur ChowdhuryDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Research Foundation, Cincinnati, OH, United States.
Elizabeth WarehamDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Research Foundation, Cincinnati, OH, United States.
Juying XuDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Research Foundation, Cincinnati, OH, United States.
Sachin KumarDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Research Foundation, Cincinnati, OH, United States.
Matthew KofronDivision of Developmental Biology, Cincinnati Children's Research Foundation, Cincinnati, OH, United States.
Sribalaji LakshmikanthanVersiti Blood Research Institute, Milwaukee, WI, United States.
Magdalena ChrzanowskaVersiti Blood Research Institute, Milwaukee, WI, United States.
Marie-Dominique FilippiDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Research Foundation, Cincinnati, OH, United States.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati Medical Center · USMedical College of Wisconsin · USVersiti Blood Center of Wisconsin · US

Funding

Rap1 in VEGF signaling in endothelial cellsR01HL111582 · NHLBI · VERSITI WISCONSIN, INC. · PI CHRZANOWSKA, MAGDALENA · 2012 to 2019
$3.3M
NHLBI NIH HHS R01 HL111582
6 · The paper itself

Abstract

Introduction: Neutrophils are critical for host immune defense; yet, aberrant neutrophil tissue infiltration triggers tissue damage. Neutrophils are heterogeneous functionally, and adopt 'normal' or 'pathogenic' effector function responses. Understanding neutrophil heterogeneity could provide specificity in targeting inflammation. We previously identified a signaling pathway that suppresses neutrophilmediated inflammation via integrin-mediated Rap1b signaling pathway. Methods: Here, we used Rap1-deficient neutrophils and proteomics to identify pathways that specifically control pathogenic neutrophil effector function. Results: We show neutrophil acidity is normally prevented by Rap1b during normal immune response with loss of Rap1b resulting in increased neutrophil acidity via enhanced Ldha activity and abnormal neutrophil behavior. Acidity drives the formation of abnormal invasive-like protrusions in neutrophils, causing a shift to transcellular migration through endothelial cells. Acidity increases neutrophil extracellular matrix degradation activity and increases vascular leakage in vivo. Pathogenic inflammatory condition of ischemia/reperfusion injury is associated with increased neutrophil transcellular migration and vascular leakage. Reducing acidity with lactate dehydrogenase inhibition in vivo limits tissue infiltration of pathogenic neutrophils but less so of normal neutrophils, and reduces vascular leakage. Discussion: Acidic milieu renders neutrophils more dependent on Ldha activity such that their effector functions are more readily inhibited by small molecule inhibitor of Ldha activity, which offers a therapeutic window for antilactate dehydrogenase treatment in specific targeting of pathogenic neutrophils

Indexed as

Endothelial CellsNeutrophilsCell MovementHumansInflammationL-Lactate DehydrogenaseNeutrophil Infiltrationrap GTP-Binding ProteinsL-Lactate DehydrogenaseRAP1B protein, humanrap GTP-Binding ProteinsinflammationLdhamigrationneutrophilsvascular leakage

Identifiers

PMID36505495
PMCPMC9733537
OpenAlexW4309949297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.